...
search icon
ints-img

Intensity Therapeutics, Inc. Common stock Share Price

INTS
NAQ
$0.2502
-$0.12
(-32.34%)
1D
Industry: Biotechnology Sector: Health Care

Intensity Therapeutics, Inc. Common stock Analyst Forecast

Intensity Therapeutics, Inc. Common stock Share Price Chart

Intensity Therapeutics, Inc. Common stock Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$22.29M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
9.33M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
4.22
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.19 L
$2.5 H
$0.2502

About Intensity Therapeutics, Inc. Common stock, Common Stock

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut. more

Industry: BiotechnologySector: Health Care

Intensity Therapeutics, Inc. Common stock Stock Returns

Time FrameINTSSectorS&P500
1-Week Return-26.88%-1.08%-1.38%
1-Month Return-38.93%-0.47%-1.81%
3-Month Return-46.62%2.13%1.38%
6-Month Return-12%17.04%5.68%
1-Year Return-88.24%6.56%11.74%
3-Year Return-95.72%16.78%65.15%

Intensity Therapeutics, Inc. Common stock Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue--179.04K147.00K25.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.11,"profit":true},{"date":"2024-12-31","value":13.96,"profit":true}]
Gross Profit--(179.04K)(147.00K)(25.00K)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-17903700,"profit":false},{"date":"2023-12-31","value":-14700000,"profit":false},{"date":"2024-12-31","value":-2500000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses6.22M8.01M7.55M8.17M16.59M[{"date":"2020-12-31","value":37.52,"profit":true},{"date":"2021-12-31","value":48.32,"profit":true},{"date":"2022-12-31","value":45.52,"profit":true},{"date":"2023-12-31","value":49.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(6.22M)(8.01M)(7.55M)(8.32M)(16.59M)[{"date":"2020-12-31","value":-622324600,"profit":false},{"date":"2021-12-31","value":-801372200,"profit":false},{"date":"2022-12-31","value":-755000000,"profit":false},{"date":"2023-12-31","value":-831900000,"profit":false},{"date":"2024-12-31","value":-1658500000,"profit":false}]
Total Non-Operating Income/Expense266.77K120.73K(111.30K)(2.20M)631.00K[{"date":"2020-12-31","value":42.28,"profit":true},{"date":"2021-12-31","value":19.13,"profit":true},{"date":"2022-12-31","value":-17.64,"profit":false},{"date":"2023-12-31","value":-348.65,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(6.03M)(7.90M)(7.58M)(10.54M)(16.27M)[{"date":"2020-12-31","value":-603048000,"profit":false},{"date":"2021-12-31","value":-789560000,"profit":false},{"date":"2022-12-31","value":-758200000,"profit":false},{"date":"2023-12-31","value":-1053800000,"profit":false},{"date":"2024-12-31","value":-1626800000,"profit":false}]
Income Taxes(74.01K)(2.61K)(131.91K)1.00-[{"date":"2020-12-31","value":-7400900,"profit":false},{"date":"2021-12-31","value":-260900,"profit":false},{"date":"2022-12-31","value":-13190800,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(5.96M)(7.89M)(7.45M)(10.54M)-[{"date":"2020-12-31","value":-595647100,"profit":false},{"date":"2021-12-31","value":-789299100,"profit":false},{"date":"2022-12-31","value":-745009200,"profit":false},{"date":"2023-12-31","value":-1053800100,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(6.03M)(7.90M)(7.58M)(10.54M)(16.27M)[{"date":"2020-12-31","value":-603048000,"profit":false},{"date":"2021-12-31","value":-789560000,"profit":false},{"date":"2022-12-31","value":-758296600,"profit":false},{"date":"2023-12-31","value":-1053800000,"profit":false},{"date":"2024-12-31","value":-1626800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(5.96M)(7.89M)(7.58M)(10.54M)(16.27M)[{"date":"2020-12-31","value":-595647100,"profit":false},{"date":"2021-12-31","value":-789299100,"profit":false},{"date":"2022-12-31","value":-758200000,"profit":false},{"date":"2023-12-31","value":-1053800000,"profit":false},{"date":"2024-12-31","value":-1626800000,"profit":false}]
EPS (Diluted)---(2.95)(2.12)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-295.14,"profit":false},{"date":"2024-12-31","value":-212,"profit":false}]

Intensity Therapeutics, Inc. Common stock Ratios

Intensity Therapeutics, Inc. Common stock Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

INTS
Cash Ratio 3.11
Current Ratio 3.60

Intensity Therapeutics, Inc. Common stock Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

INTS
ROA (LTM) -101.66%
ROE (LTM) -234.70%

Intensity Therapeutics, Inc. Common stock Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

INTS
Debt Ratio Lower is generally better. Negative is bad. 0.25
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.75

Intensity Therapeutics, Inc. Common stock Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

INTS
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 3.10
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Intensity Therapeutics, Inc. Common stock share price today?

Intensity Therapeutics, Inc. Common stock (INTS) share price today is $0.2502

Can Indians buy Intensity Therapeutics, Inc. Common stock shares?

Yes, Indians can buy shares of Intensity Therapeutics, Inc. Common stock (INTS) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in INTS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Intensity Therapeutics, Inc. Common stock be purchased?

Yes, you can purchase fractional shares of Intensity Therapeutics, Inc. Common stock (INTS) via the Vested app. You can start investing in Intensity Therapeutics, Inc. Common stock (INTS) with a minimum investment of $1.

How to invest in Intensity Therapeutics, Inc. Common stock shares from India?

You can invest in shares of Intensity Therapeutics, Inc. Common stock (INTS) via Vested in three simple steps:

  • Click on Sign Up or Invest in INTS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Intensity Therapeutics, Inc. Common stock shares
What is Intensity Therapeutics, Inc. Common stock 52-week high and low stock price?

The 52-week high price of Intensity Therapeutics, Inc. Common stock (INTS) is $2.5. The 52-week low price of Intensity Therapeutics, Inc. Common stock (INTS) is $0.19.

What is Intensity Therapeutics, Inc. Common stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Intensity Therapeutics, Inc. Common stock (INTS) is

What is Intensity Therapeutics, Inc. Common stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Intensity Therapeutics, Inc. Common stock (INTS) is 3.10

What is Intensity Therapeutics, Inc. Common stock dividend yield?

The dividend yield of Intensity Therapeutics, Inc. Common stock (INTS) is 0.00%

What is the Market Cap of Intensity Therapeutics, Inc. Common stock?

The market capitalization of Intensity Therapeutics, Inc. Common stock (INTS) is $22.29M

What is Intensity Therapeutics, Inc. Common stock's stock symbol?

The stock symbol (or ticker) of Intensity Therapeutics, Inc. Common stock is INTS

How Can Investors Use Intensity Therapeutics, Inc. Common stock Share Price Data for Long-Term Investment Decisions?

Consider the share price of Intensity Therapeutics, Inc. Common stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Intensity Therapeutics, Inc. Common stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Intensity Therapeutics, Inc. Common stock shares for Indian investors?

When investing in Intensity Therapeutics, Inc. Common stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Intensity Therapeutics, Inc. Common stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Intensity Therapeutics, Inc. Common stock share price with other stocks in the same sector?

Rather than merely checking the share price of Intensity Therapeutics, Inc. Common stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Intensity Therapeutics, Inc. Common stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top